XM does not provide services to residents of the United States of America.
A
A

Agilent


News

Italy - Factors to watch on October 24

Italy - Factors to watch on October 24 The following factors could affect Italian markets on Thursday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . DEBT Treasury announces sale of 6-month BOT bills, with relative amounts to be auctioned on Oct.
A
C
E
E
I
S
U
I
T
I
U

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change United Airlines Holdings Inc UAL.OQ +13.9% Delta Air Lines Inc DAL.N +6.9% Morgan Stanley MS.N +6.7% Walgreens Boots Alliance Inc WBA.OQ +5.8% Synchrony Financial SYF.N +5.7% Bottom Performers Percent Change Mettler-Toledo Internationa
A
W
U
U
M
S

Bernstein expects a 'not so scary' Q3 for US life sciences firms

BUZZ-Bernstein expects a 'not so scary' Q3 for US life sciences firms ** Brokerage Bernstein expects a "not so scary" Q3 earnings season for U.S. life sciences and tools firms, which "would be a real treat" for investors ** "With the recovery timeline for life science tools continuing to push out (further), some investors feel like they have been t
A
I
T
W

Low-cost hybrid tech gives Renault breathing space in tough EV transition

FOCUS-Low-cost hybrid tech gives Renault breathing space in tough EV transition Renault's hybrid sales rise 55% in January-August French carmaker's low-cost hybrid tech uses fewer parts Renault's EV sales stagnant, needs 20% EV sales to meet 2025 CO2 targets - source By Gilles Guillaume PARIS, Oct 14 (Reuters) - Renault CEO Luca de Meo's bet on a low-cost gearbox technology is allowing the French carmaker to gain ground in Europe's fast-growing hybrid car market, giving it some breathing space a
A
P
R
T
V
V

Agilent Technologies Inc Files For Two-Part Senior Notes Offering Size Not Disclosed - SEC Filing

BRIEF-Agilent Technologies Inc Files For Two-Part Senior Notes Offering Size Not Disclosed - SEC Filing Agilent Technologies Inc A.N : AGILENT TECHNOLOGIES INC FILES FOR TWO-PART SENIOR NOTES OFFERING; SIZE NOT DISCLOSED - SEC FILING Source text for Eikon: [ID:n0001193125-24-212662] Further company coverage: A.N
A

U.S. Advance Auto Parts, Chewy, Workday

U.S. RESEARCH ROUNDUP-Advance Auto Parts, Chewy, Workday Aug 23 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Advance Auto Parts, Chewy and Workday, on Friday. HIGHLIGHTS * Advance Auto Parts Inc AAP.N : JP Morgan cuts target price to $43 from $55 * Chewy CHWY.N : Piper Sandler raises to overweight from neutral * Intuit Inc INTU.O : Jefferies raises target price to $790 from $770 * Williams-Sonoma Inc WSM.N : TD Co
A
A
A
B
I
J
N
N
R
R
H
A

U.S. STOCKS NetEase, Wolfspeed, B. Riley

BUZZ-U.S. STOCKS ON THE MOVE-NetEase, Wolfspeed, B. Riley Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell in volatile trading on Thursday, as rising Treasury yields pressured stocks ahead of Federal Reserve Chair Jerome Powell's speech at Jackson Hole that could offer clues on the possibility of a rate cut next month.
A
B
N
S
U
U
U
E
S
A

U.S. STOCKS Evogene, Stryker, Opera

BUZZ-U.S. STOCKS ON THE MOVE-Evogene, Stryker, Opera Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell in volatile trading on Thursday, as rising Treasury yields pressured stocks ahead of Federal Reserve Chair Jerome Powell's speech at Jackson Hole that could offer clues on the possibility of a rate cut next month.
A
B
B
I
N
U
U
U
E
S
A

Agilent Technologies rises on Q3 results beat

BUZZ-Agilent Technologies rises on Q3 results beat ** Shares of medical equipment maker Agilent Technologies A.N rise 3.6% to $145.03 after Q3 results ** Company reports Q3 revenue of $1.58 bln; above Wall Street expectations of $1.56 bln - LSEG data ** Quarterly adj EPS of $1.32 beat market estimate of $1.26 ** Co forecasts Q4 revenue between $1.6
A

U.S. Aadi Bioscience, Target, Visteon

U.S. RESEARCH ROUNDUP-Aadi Bioscience, Target, Visteon Aug 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aadi Bioscience, Target and Visteon, on Thursday. HIGHLIGHTS * Aadi Bioscience Inc AADI.O : Jefferies cuts to hold from buy * Assurant Inc AIZ.N : Piper Sandler cuts to neutral from overweight * Estée Lauder EL.N : Piper Sandler raises to overweight from neutral * Target Corp TGT.N : Jefferies raises target
A
A
H
S
T
T
U
A
P
U
D
E
A

Agilent Technologies Inc reports results for the quarter ended in July - Earnings Summary

Agilent Technologies Inc reports results for the quarter ended in July - Earnings Summary Agilent Technologies Inc A.N reported quarterly adjusted earnings of $1.32​​ per share for the quarter ended in July, lower than the same quarter last year, when the company reported EPS of $1.43. The mean expectation of seventeen analysts for the quarter was for earnings of $1.26 per share.
A

Agilent beats quarterly results on strong demand from biotech clients

Agilent beats quarterly results on strong demand from biotech clients Aug 21 (Reuters) - Agilent Technologies A.N on Wednesday beat Wall Street estimates for third-quarter profit and revenue, banking on strong demand for its medical tools and equipment used in clinical studies. "While market conditions continued to be challenged during the quarter, we saw steady signs of improvement as anticipated", said CEO Padraig McDonnell.
A
T

Agilent Q3 Revenue USD 1,578 Million Vs. IBES Estimate USD 1,558 Million

BRIEF-Agilent Q3 Revenue USD 1,578 Million Vs. IBES Estimate USD 1,558 Million Aug 21 (Reuters) - Agilent Q3 income from operations USD 333 million. Q3 net income USD 282 million Q3 pretax profit USD 343 million vs. IBES estimate USD 428.4 million Q3 EPS USD 0.97 Q3 adjusted net income USD 385 million vs. IBES estimate USD 371 million Q3 adjusted EPS USD 1.32 vs.
A

Agilent Technologies Inc <A.N> expected to post earnings of $1.26 a share - Earnings Preview

Agilent Technologies Inc expected to post earnings of $1.26 a share - Earnings Preview Agilent Technologies Inc A.N , A is expected to show a fall in quarterly revenue when it reports results on August 21 for the period ending January 1 0001 The Santa Clara California-based company is expected to report a 6.8% decrease in revenue to $1.558 billion from $1.67 billion a year ago, according to the mean estimate from 14 analysts, based on LSEG data.The company's guidance on May 29 2024, for the peri
A

U.S. earnings week ahead

DIARY-U.S. earnings week ahead Aug 16 (Reuters) - Diary of U.S. (.SPX) corporate earnings for the week ahead. ** Please Note - All times given are in U.S. EDT unless otherwise stated ** U.S. EARNINGS Start Date Start Time RIC Company Name Event Name 19-Aug-2024 AMC PANW.O Palo Alto Networks Inc Q4 2024 Palo Alto Networks Inc Earnings Release 19-Aug-2024 BMO EL Estee Lauder Companies Inc Q4 2024 Estee Lauder Companies Inc Earnings Release 20-Aug-2024 AMC KEYS Keysight Technologies Inc Q3 2024 Key
A
I
A
R
U
E
K



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.